There are fair objections and concerns to secretary of defense nominee Pete Hegseth, but a Jerusalem Cross tattoo isn’t one of them.

Amanda Holden has unveiled her first tattoo after going away on a girls holiday. The Britain's Got Talent judge opened up about the ink on her Heart Breakfast show, revealing she convinced a friend to ...

By Emilia Petrarca If laundry is a chore, hand washing might feel like punishment. Who has the time, let alone the space, to soak and lay out to dry large, delicate garments? Running to the dry ...

Every tattoo tells a tale, be it an emblem of remembrance, a stroke of creativity, or a whimsy from wild nights like stag dos. And now tattoo artists have lifted the veil on their most and least ...

SAN AN­TO­NIO — Promis­ing da­ta don’t al­ways equal a stock pop. Viking Ther­a­peu­tics pre­sent­ed what an­a­lysts thought were com­pelling da­ta on an oral … ...

We still recommend the disposable HotHands Hand Warmers for inside your gloves. October 2024 Ever heard the saying, “There’s no such thing as bad weather—just bad clothes”? This most ...

Getty Images Viking Therapeutics shares fell Monday after reporting the latest results from trials of its weight-loss drugs. Analysts say the treatment, which is being tested in both oral and ...

Pete Davidson gave fans a look into his tattoo removal process in a surprise guest appearance on “Saturday Night Live.” During the sketch, Davidson wore a short-sleeved graphic T-shirt that re ...

Viking Therapeutics is rowing its longboat toward the front of the oral obesity therapy race, posting detailed phase 1 data that suggest its dual agonist of GLP-1 and GIP can hold its own in a ...

SAN AN­TO­NIO — Viking Ther­a­peu­tics’ high­ly an­tic­i­pat­ed read­out of its oral an­ti-obe­si­ty pill showed a place­bo-ad­just­ed weight loss of 6.8% af­ter four weeks ...

Viking’s results provided the latest showcase of how much Wegovy and Zepbound’s market success has heightened investor attention on preliminary findings from small studies. The data are from a Phase 1 ...